Ants could be the next line of defense against cancer.
A study published in the journal Proceedings of Royal Society B: Biological Sciences focused on Ants and their keen sense of smell. Ants use smell via their thin sensory appendages that sit on top of their heads to do almost everything, including hunt for food, spotting mates, and protecting their young.
In the study, scientists used pieces of a breast cancer tumor, which were grafted onto mice, and then trained 35 ants to associate urine from the infected mice with sugar. In analyzing, scientists detected that the ants would hover for longer periods of time near the sick mouse rather than the healthy one.
Using ants to detect cancers would be a cost-cutting tool. Currently, cancers are diagnosed by blood withdrawal, biopsies, and colonoscopies, which are all considered invasive as well as being expensive procedures. Utilizing ants to screen for cancer would be significantly more reasonable.
While dogs have similar capabilities in that they are able to detect cancer in humans through smell, they take much longer to train. Baptiste Piqueret, a postdoctoral fellow at the Max Planck Institute for Chemical Ecology in Germany, said ants would be the ideal animal to use because they have good memories, are easy to train and don't bite.
Though progress has been made with ants and their cancer detection capabilities, there is still more research to be done on their efficacy. The next phase of the study will be human trials to see if ants are able to sniff out cancers through human excrement.
A new report from Dr. Michael Worobey alleges that it is likely that COVID-19 originated from a raccoon dog at the Wuhan live animal market in China. While his report does not rule out the coronavirus could have escaped from a lab, Worobey's evidence points to a natural origin.
Jill and Carlo are back to cover the latest in the Rittenhouse trial, new information on the origins of Covid, return-to-office and more.
JOIN US FOR THE YOUTUBE WATCH PARTY @ 9aET: http://www.youtube.com/cheddarnow
Over the weekend, Russia fired a missile at one of its own satellites, triggering an explosion that launched thousands of pieces of shrapnel through space and forced the astronauts aboard the International Space Station to shelter in place. Senior Writer from Space.com Chelsea 'Foxanne' Gohd, joined Cheddar to discuss more.
Gerald Comissiong, CEO of Todos Medical, joins None of the Above to discuss why we're seeing surges of COVID-19 cases in Europe, the potential for a winter surge of COVID-19, the benefits of high vaccination rates in a community, and the coming COVID treatment pills.
Cognitive healthcare platform BrainCheck recently raised $10 million in a Series B round. The platform offers neurologists a new way to detect and care for brain disorders like Alzeheimer's, and brain injuries like concussions. BrainCheck CEO Yael Katz joined Cheddar News' Closing Bell to discuss.
On this episode of Cheddar Innovates: Ice Barrel CEO breaks down the physical and mental health benefits to cold therapy training; Dishcraft CEO explains how its robotics is transforming the role of a dishwasher in restaurant kitchens; A look at Curiosity Stream's original series 'The Year That Rocked The World.'
Jill Wagner is joined by Baker to talk about kids and vaccines: we finally know how many young kids are getting vaccinated. Plus, Democrats are working on a Plan B for paid family leave. And the salad chain Sweetgreen goes public.
A breakthrough deal between the U.S. and China when it comes to climate has finally been reached. The two countries have pledged to work together to curb carbon emissions. Amy Harder, executive editor at Cipher, joined Cheddar News to discuss more.
Joey Roulette, space reporter for The New York Times, joined Cheddar to break down the intense backlash Russia is seeing after its missile test sent destroyed a non-functioning satellite and sent thousands of pieces of debris potentially at the ISS, endangering astronauts onboard. He said while the blast happened days ago, there is still some risk to the station as the space junk threat remains. So far, the U.S., NATO, and the European Union have condemned Russia for the test.
Jill is joined by “Friend of the Pod” Mosheh Oinounou to talk booster shots, and whether “fully vaccinated” will eventually mean three shots, not two. Plus, the latest on the Kyle Rittenhouse trial. And the research is in: we know now the perfect way to hug. Also, Jill and Mosheh debate whether Airpods are passé.
